Serious infections in children: an incidence study in family practice by Van den Bruel, Ann et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Family Practice
Open Access Research article
Serious infections in children: an incidence study in family practice
Ann Van den Bruel*1, Stefaan Bartholomeeusen1, Bert Aertgeerts1, 
Carla Truyers1 and Frank Buntinx1,2
Address: 1Academisch Centrum voor Huisartsgeneeskunde, Katholieke Universiteit Leuven, Leuven, Belgium and 2Department of General Practice, 
Universiteit Maastricht, Maastricht, The Netherlands
Email: Ann Van den Bruel* - ann.vandenbruel@med.kuleuven.be; Stefaan Bartholomeeusen - stefaan.bartholomeeusen@med.kuleuven.be; 
Bert Aertgeerts - bert.aertgeerts@med.kuleuven.be; Carla Truyers - carla.truyers@med.kuleuven.be; 
Frank Buntinx - frank.buntinx@med.kuleuven.be
* Corresponding author    
Abstract
Background: Information on the incidence of serious infections in children in general practice is
scarce. However, estimates on the incidence of disease are important for several reasons, for
example to assess the burden of disease or as a basis of diagnostic research. We therefore
estimated the incidence of serious infections in general practice in Belgium.
Methods:  Intego is a morbidity registration network, in which 51 general practitioners
continuously register all diagnoses and additional data in their electronic medical records. Serious
infections were defined as pneumonia, sepsis, meningitis, pyelonephritis and osteomyelitis.
Incidences are calculated for the period of 1998 to 2002, per 1000 patients in the yearly contact
group, which is the group of patients that consulted their GP at least once that year, and in the
practice population, which is the estimated true population of that practice.
Results: The incidence of all infectious diseases peaks in children between 0 and 4 years, with 1731
infections per 1000 children per year in the yearly contact group. Incidence drops with increasing
age: 972 infections per 1000 children per year in children between 5 and 9 years old, and 732 in
children between 10 and 14 years old. The same decline in incidence is observed in the subgroup
of serious infections: 21 infections per 1000 children per year in children between 0 and 4 years,
12 in children between 5 and 9 years and 5 in children between 10 and 14 years. The results for
the estimated practice population are respectively 17, 9 and 4 serious infections per 1000 children
per year.
Conclusion: In contrast to the total incidence of acute infections, serious infections are rare,
around 1% per year. Children younger than 4 years old have the highest risk for serious infections,
and incidences of some infections are different for boys and girls.
Background
The incidence of acute infections in children is high.
Using data from the English fourth Practice-Based Mor-
bidity Survey, children under 1 year of age reported an
average of 3.3 infections in a year, and 1.2 infections in
the age group 1–15 years [1]. Acute upper respiratory
infection is the dominant diagnosis, which is essentially a
harmless, self-limiting disease.
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However, some infections can have serious consequences.
For example, bacterial meningitis leads to mortality in 5%
of the cases and morbidity, such as hearing loss, in 10%–
15%[2]. Up to 24% mortality after meningococcal dis-
ease, being sepsis or meningitis, has been reported[3]. In
developing countries, pneumonia and diarrhoea are two
of the leading causes of mortality in children under the
age of 5[4]. In the period of 1989–1993, infectious dis-
eases were responsible for 7.5% of all deaths in children
under the age of 1, and for 9.3% of all deaths in children
between 1 and 14 years old in the Northern region of the
UK[5].
Serious infections are usually defined as serious bacterial
infections: pneumonia, sepsis, meningitis, pyelonephritis,
bacterial gastro-enteritis, osteomyelitis and cellulitis. [6-
9]. However, pneumonia and meningitis are often caused
by viruses and other viral infections can be serious as well,
for example bronchiolitis. In general practice, bacterial
aetiology is difficult to establish and the serious nature of
the infection is sometimes determined by the need for
interventions such as hospitalization or specific treat-
ment. Therefore, in primary care pneumonia, sepsis, men-
ingitis, bacterial gastro-enteritis, pyelonephritis,
osteomyelitis and bronchiolitis can be considered serious
infections.
The diagnosis of a serious infection is difficult in general
practice, as the majority of the infections presented to the
general practitioner is not serious and the initial presenta-
tion of serious and non-serious infections can be similar.
Still, early diagnosis of a serious infection is important to
avoid delay in treatment and improve prognosis [10-12].
There is very limited information on the incidence of seri-
ous infections in general practice. Most studies were per-
formed in hospital. They have found serious infections
such as pneumonia, meningitis, sepsis and bacterial gas-
troenteritis to be present in up to 25% of febrile infants
presenting to the emergency department[13,14]. These
results can not be transferred to general practice, because
of the large differences between the populations. Other
studies in general practice have reported incidences for
individual infections [15-17], but differences in health
care structure limit the applicability to the Belgian con-
text.
Therefore, we conducted this study to calculate the age-
specific incidence of serious infections in children, seen in
general practice in Belgium. Additionally, we determined
the proportion of serious infections in the entire group of
children with an acute infection and we studied seasonal
influence.
Methods
Intego is a morbidity registration network, coordinated by
the department of general practice of the Katholieke Uni-
versiteit Leuven. 51 general practitioners in 43 practices
continuously register all diagnoses and additional data in
their electronic medical records. These practices have been
selected by the quality of their registration. The informa-
tion is automatically extracted from the records on a
Table 2: total incidence rates of all acute infections and serious infections per 1000 patients per year for each age category, between 
1998–2002.
Denominator 0–4 (95% CI) 5–9 (95% CI) 10–14 (95% CI) Total incidence 
(95% CI)
Acute infections Yearly contact group 1731.7 (1708 – 1754) 972.5 (970 – 975) 732.5 (725 – 738) 1106.6 (1097 – 1116)
Practice population 1383.0 (1365 – 1401) 732.7 (727 – 739) 527.8 (521 – 533) 833.8 (830 – 836)
Serious infections Yearly contact group 21.1 (17.9 – 22.9) 11.7 (9.8 – 13.2) 5.1 (4.0 – 6.3) 12.0 (10.9 – 12.9)
Practice population 16.8 (14.3 – 18.3) 8.8 (7.4 – 10.0) 3.6 (2.9 – 4.5) 9.3 (8.2 – 9.7)
Table 1: ICPC-2 coded diagnoses, included in the study. (* 
serious infections)
A03 fever
A71 measles
A72 chickenpox
A74 rubella
A75 mononucleosis infectiosa
A76 other viral infection with exanthema
A77 other viral infection
A78 other infection not otherwise specified
D70 gastro-intestinal infection
D71 mumps
D73 supposed infectious gastro-enteritis
H71 otitis media acuta
L70 infection of the limbs*
N71 meningitis/encephalitis + sepsis*
R71 whooping-cough
R72 streptococcal angina
R74 acute infection of the upper respiratory tract
R75 acute/chronic sinusitis
R76 acute tonsillitis
R77 acute laryngitis/tracheitis
R78 acute bronchitis/bronchiolitis
R80 influenza (ex pneumonia)
R81 pneumonia *
R83 other infection of the respiratory tract
U70 pyelonephritis/pyelitis *
U71 acute cystitisBMC Family Practice 2006, 7:23 http://www.biomedcentral.com/1471-2296/7/23
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yearly basis and collected in a central database. Diagnoses
are classified according to a very detailed diagnostic clas-
sification list and converted into ICPC-2 codes[18,19].
As there is free access to all physicians in Belgium, and
patients are not forced to register to a practice, it is difficult
to establish the practice population. This is particularly
important as the incidence of a disease in a certain prac-
tice equals all new cases of this disease in that practice, in
the nominator, divided by the practice population in the
denominator. Until recently, only the group of patients
that had consulted their GP at least once in that year has
been used as denominator, called the Yearly Contact
Group. But, as it was hypothesised that some factors have
an influence on the consultation rate of a patient, for
example age, gender or social status, it was not possible to
extrapolate this Yearly Contact Group to the total practice
population, because these influencing factors can be
present in certain practices more than in others. Now, data
of the Health Insurance Agency have been made available,
by which it was possible to estimate a practice population,
starting from the Yearly Contact Group and taking age,
gender and region into account. This population will be
referred to as the Practice Population. A more detailed
description of this methodology has been published else-
where[20].
For children, the difference between the Yearly Contact
Group and the Practice Population is particularly large,
because some children never consult a general practi-
tioner but only a paediatrician. This makes the estimation
of a practice population less appropriate for this age
group, because the extrapolation to a larger group that
never visits the general practitioner is not very useful.
For this reason, the main outcome measures are presented
for both the Yearly Contact Group and the Practice Popu-
Monthly incidence of acute infections per 1000 children of the Yearly Contact Group, between 1998 – 2002 Figure 2
Monthly incidence of acute infections per 1000 children of the Yearly Contact Group, between 1998 – 2002.
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Annual incidence of acute infections per 1000 children of the Yearly Contact Group, from 1998 to 2002.
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lation. Secondary outcome measures are presented for the
Yearly Contact Group only.
Incidences are calculated as the number of events per
1000 patient-years and based upon the data from 1998 to
2002. If a disease occurred more than once during the
study period, each occurrence was calculated.
The diagnoses that were analysed are presented in table 1,
with their corresponding ICPC-2 code. Serious infections
are marked with *.
The ICPC-A78 code, other infection not otherwise speci-
fied, contains several diagnoses, including sepsis. We
extracted the individual diagnoses of sepsis from this
group and added them to the code of meningitis, resulting
in a combined diagnostic category meningitis/encephali-
tis/sepsis. On the basis of our data, it was impossible to
identify bacterial gastro-intestinal infections within the
large group of all gastro-intestinal infections, neither was
it possible to separate bronchiolitis from acute bronchitis.
These infections could therefore not be included in the
selection of serious infections. Serious infections were
therefore defined as pneumonia, sepsis, meningitis,
osteomyelitis and pyelonephritis.
Analyses were performed with STATA statistical software
and Epi-info. 95% confidence intervals are based upon a
Poisson distribution if there were 100 cases or less, and on
a Normal distribution in all other cases. Differences
between age groups were tested with chi2 for trend. A
trend over subsequent years was analysed with linear
regression analysis, using the year as the independent and
yearly incidence as the dependent variable. The seasonal
influence was tested in SAS with the combined test for the
presence of identifiable seasonality, which is a joint test of
both stable and moving seasonality. In the first test, the
null-hypothesis is that there is no difference in incidence
between seasons. The second test tests whether the sea-
sonal incidence has moved over the last years.
Results
Demographics
The Yearly Contact Group consisted in 1998 to 2002 of
45,654 patient years between 0 and 14 years old, of which
47.9% were girls. The total Practice Population is esti-
mated at 60,598 patient years, of which 48.1% were girls.
Acute infections
The age-specific incidence rates for the total group of the
selected acute infections and for the subgroup of serious
Table 3: annual incidence rates of acute infections, in the Yearly Contact Group, per 1000 children, from 1998–2002. (* serious 
infections)
0 – 4 years 5 – 9 year 10 – 14 years Total
A03 fever 34.9 8.2 2.8 14.0
A71 measles 0.68 0.19 0.13 0.28
A72 chicken pocks 59.7 13.1 1.3 22.4
A74 rubella 0.30 0.63 0.11 0.33
A75 mononucleosis infectiosa 0.68 1.65 2.29 1.60
A76 other viral infection with exanthema 4.5 1.3 0.4 1.9
A77 other viral infection 21.2 11.6 9.7 13.7
A78 other infection nos 8.6 5.1 1.9 4.9
D70 gastro-intestinal infection 10.6 3.1 2.6 5.1
D71 mumps 0.6 0.3 0.5 0.5
D73 supposed infectious gastro-enteritis 130.9 92.1 84.2 100.5
H71 otitis media acuta 226.4 108.8 39.0 117.7
L70 infection of the limbs* 0.45 0.38 0.42 0.42
N71 meningitis/encephalitis + sepsis* 1.4 1.1 0.06 0.7
R71 whooping-cough 0.23 0.00 0.00 0.07
R72 streptococcal angina 0.38 0.44 0.36 0.39
R74 acute infection of the upper respiratory tract 666.5 339.4 292.9 417.8
R75 acute/chronic sinusitis 8.3 18.3 23.1 17.2
R76 acute tonsillitis 87.4 81.7 47.0 70.7
R77 acute laryngitis/tracheitis 84.5 49.7 35.3 54.6
R78 acute bronchitis///bronchiolitis 201.0 89.0 48.5 106.9
R80 influenza (ex pneumonia) 123.7 113.1 118.5 118.1
R81 pneumonia * 18.1 9.9 4.3 10.2
R83 other infection of the respiratory tract 26.7 13.1 10.2 16.0
U70 pyelonephritis/pyelitis * 1.3 0.6 0.4 0.7
U71 acute cystitis 12.8 10.3 6.7 9.7BMC Family Practice 2006, 7:23 http://www.biomedcentral.com/1471-2296/7/23
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infections are listed in table 2. Total incidence for all age
groups is 1107 acute infections per 1000 patients per year
in the Yearly Contact Group or approximately 1.1 infec-
tions per child per year. In contrast, the incidence of seri-
ous infections is 12.3 per 1000 patients per year, or just
over 1 serious infection per 100 children per year. Serious
infections account for 1.1% of the acute infections in chil-
dren selected for this study.
The incidence of infectious diseases peaks in very young
children between 0 and 4 years old, with 1731 infections
per 1000 children per year. Incidence drops with increas-
ing age: 972 infections per 1000 children per year in chil-
dren between 5 and 9 years old, and 732 in children
between 10 and 14 years old. The same decline in inci-
dence is observed in the subgroup of serious infections: 21
infections per 1000 children per year in children between
0 and 4 years, 12 in children between 5 and 9 years and 5
in children between 10 and 14 years. These results all
apply to the Yearly Contact Group, which is the group of
children that consulted their general practitioner at least
once during one year. The results for the estimated Prac-
tice Population are on average 25% lower than that of the
Yearly Contact Group.
When testing the differences between the age groups with
chi2 for trend, these are highly significant, both for the
total group of infections and for the serious infections,
with p-values < 0,001. For serious infections, the odds
ratios are 0.56 and 0.25 for children between 5 – 9 years
and 10 – 14 years respectively, compared to the group
between 0 – 4 years.
It has been suggested that there is a decline in incidence of
acute infections over recent years[21]. For this reason, we
have analysed the annual incidence for each year sepa-
rately. Although annual incidence of acute infections
appears to be declining, there has been a small rise in the
annual incidence in 2002 (figure 1). A linear regression
analysis shows that there is a marginally significant
decline in yearly incidence of 58 acute infections per 1000
children per year from 1998 to 2002 (p = 0.05). A similar
decline is to be observed when only respiratory acute
infections are considered.
The monthly incidence rates are shown in figure 2. Testing
for seasonality, there is a higher incidence in the winter for
ICPC-codes H71 (otitis media) and the codes R71–R81
(respiratory tract infections) (F < 0.05). These higher inci-
dences are stable over recent years (F > 0.05). Codes A03
and A71–78, being fever and various viral infections, did
not show a significant seasonality (F > 0.05).
The incidence per 1000 children per year for each ICPC-2
code is listed in table 3. Considering diagnostic groups
separately, the high incidence of acute upper respiratory
tract infections (R74) is very prominent: 417 per 1000
patients per year. In children between 0 and 4 years old,
this incidence rises to 666 per 1000 per year. When other
diagnoses concerning the upper respiratory tract are
added, incidence is even higher, being 812 infections per
1000 children of all age groups per year or more than half
of all cases. Similar to other diagnostic categories, the
youngest children have the highest incidence rate, except
for the diagnosis of sinusitis.
Table 4: annual incidence rates of serious infections, in the Yearly Contact Group, per 1000 children, from 1998–2002.
0–4 years (95% CI) 5–9 years (95% CI) 10–14 years (95% 
CI)
Total (95% CI)
Pneumonia girls 19.0 (15.8 – 22.7) 10.2 (8.03 – 12.7) 4.0 (2.76 – 5.67) 10.5 (8.78 – 11.5)
boys 17.3 (14.2 – 22.1) 9.6 (7.64 – 12.0) 4.5 (3.21 – 6.18) 10.0 (8.46 – 11.0)
total 18.1 (15.8 – 20.5) 9.9 (8.06 – 11.1) 4.3 (3.34 – 5.40) 10.25 (9.18 – 11.0)
Pyelonephritis/pyelitis girls 1.6 (0.75 – 2.91) 0.9 (0.371 – 1.90) 0.5 (0.014 – 1.28) 1.0 (0.59 – 1.47)
boys 1.0 (0.40 – 2.06) 0.2 (0.03 – 0.88) 0.2 (0.028 – 0.84) 0.4 (0.231 – 0.83)
total 1.3 (0.74 – 2.04) 0.6 (0.26 – 1.08) 0.4 (0.13 – 0.79) 0.7 (0.48 – 0.99)
Meningitis/Sepsis girls 1.4 (0.65 – 2.71) 0.5 (0.015 – 1.35) - 0.6 (0.32 – 1.02)
boys 1.3 (0.59 – 2.45) 1.3 (0.50 – 2.09) 0.1 (0.03 – 6.46) 0.8 (0.45 – 1.19)
total 1.4 (0.80 – 2.14) 1.1 (0.44 – 1.41) 0.06 (0.02 – 3.36) 0.7 (0.48 – 0.99)
Infection of the limbs girls 0.2 (0.004 – 0.88) 0.4 (0.082 – 1.16) 0.4 (0.078 – 1.10) 0.3 (0.12 – 0.66)
boys 0.7 (0.23 – 1.67) 0.4 (0.076 – 1.07) 0.5 (0.13 – 1.19) 0.5 (0.26 – 0.88)
total 0.5 (0.17 – 0.98) 0.4 (0.14 – 0.83) 0.4 (0.17 – 0.87) 0.4 (0.25 – 0.65)
Total girls 21.7 (17.2 – 26.2) 12.0 (9.67 – 14.8) 4.9 (3.48 – 6.69) 12.2 (10.5 – 13.4)
boys 20.3 (16.9 – 23.6) 11.4 (9.17 – 13.9) 5.2 (3.81 – 7.00) 11.7 (10.4 – 13.2)
total 21.1 (17.9 – 22.9) 11.7 (9.81 – 13.2) 5.1 (4.04 – 6.27) 12.0 (10.9 – 12.9)BMC Family Practice 2006, 7:23 http://www.biomedcentral.com/1471-2296/7/23
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Serious infections
The serious infections, for which incidence calculations
were possible, are listed in table 4. Pneumonia is the most
frequent serious infection in children, accounting for
more than four fifth of the total annual incidence.
Except for infection of the limbs, all infections are most
frequent in the youngest children.
The evolution of the yearly incidence of each serious infec-
tion is shown in figure 3. It is influenced mainly by the
incidence of pneumonia. The decline of the annual inci-
dence of the group of serious infections in 1999 can there-
fore be explained by the decline of annual incidence of
pneumonia. Ignoring this drop, there could be a decline
in annual incidence, parallel to that of the total group of
acute infections. However, a linear regression analysis
based on all subsequent years does not show any signifi-
cant decline in yearly incidence (p = 0.49).
There is a peak of the annual incidence of meningitis in
2000, followed by a steep decline in the two years after-
wards (figure 3). Pyelonephritis and infections of the
limbs do not show any particular trend.
The absolute numbers of cases of pneumonia and all res-
piratory infections in each month are given in Figure 4.
Similar as all respiratory infections, the incidence rates of
pneumonia are significantly higher during the winter (fig-
ure 4) (F < 0.05). This seasonal trend is stable over the last
years (F > 0.05).
The incidence rates of meningitis do not show a similar
variation over the different months as pneumonia. The
combined seasonality test showed a higher incidence in
the fall, but this was not stable over the last years. Pyelone-
phritis shows a higher incidence in spring and summer,
which was stable over the last years (F < 0.05 and >0.05
respectively).
Discussion
The incidence of acute infections in children is high. For
every 1000 children between 0 and 14 years, over 1100
Annual incidence of the serious infections per 1000 children of the Yearly Contact Group, from 1998 to 2002 Figure 3
Annual incidence of the serious infections per 1000 children of the Yearly Contact Group, from 1998 to 2002.
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acute infections are presented to the general practitioner
in Belgium every year. The vast majority of these infec-
tions are self-limiting upper respiratory tract infections.
In contrast, serious infections are relatively rare: only 12.0
serious infections per year in every 1000 children between
0 and 14 years old. This is an annual incidence of little
more than 1%, and accounts for 1.1% of the selected acute
infections in this age group. As we were unable to separate
bacterial gastro-intestinal infections or bronchiolitis, the
true incidence of serious infections is higher, especially in
the youngest age group.
Incidence of acute infections seems to be declining over
the last five years, which has been described before[21].
For serious infections, this evolution is less clear.
In 2000, there was an outbreak of meningococcal C infec-
tions in Western Europe, leading to widespread vaccina-
tion programmes in children. This is reflected in our
results.
Incidences are highest in the youngest children between 0
and 4 years old. This is true for all acute infections (1732
per 1000 patients per year in the age group 0 to 4 years
Absolute number of cases of pneumonia and respiratory infections monthly, in the Yearly Contact Group, between 1998– 2002* Figure 4
Absolute number of cases of pneumonia and respiratory infections monthly, in the Yearly Contact Group, 
between 1998–2002*. *The axis for pneumonia is situated on the left of the figure, the axis for respiratory infections on the 
right.
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compared to 1107 in all children, which is an excess of
64%), as well as for serious infections only (21.0 between
0 and 4 years compared to 12.3 in all children, which is an
excess of 75%). This peak incidence during the first years
of life has been described before [22-25]. The only excep-
tion in our data was the incidence of sinusitis, where inci-
dence rises with increasing age. This can be explained by
the fact that sinuses are not yet well developed in very
young children.
Incidence rates vary during the year, with all acute infec-
tions and pneumonia being more frequent in the winter
months. For other serious infections, no particular pattern
could be observed, although the peak of meningitis in the
fall and that of pyelonephritis in the warmer season need
to be examined further.
Our results were subsequently compared to other morbid-
ity registrations. Data from three neighbouring registra-
tions were available, being the Transition project21 and
the Continuous Morbidity Registration (CMR), both from
the Netherlands, and the Weekly Returns Service, from the
UK[21]. Data were not available from all networks for
every diagnosis, except for pneumonia, but the incidences
of the Intego network, the Transition project and the
Weekly Returns Service are within the same range.
The CMR reports higher incidences for pneumonia as the
other three registrations: in children aged 0 – 4 years, the
yearly incidence is 27–30 per 1000 patients, as compared
to 18.3 in the Transition project, 18.1 in our present study
based on Intego and 15.7 in the Weekly Returns Service
(the latter is based on children from 1–4 years old).
Another outlier is the very high incidence of meningitis in
children under the age of one, reported by the UK Weekly
Returns Service: 9.4 infections per 1000 children per year,
as compared to a yearly incidence of 1.4 per 1000 in
Intego and 1.3 per 1000 in the Transition project, both
based however on children from 0 to 4 years old.
But, any comparison between the different morbidity reg-
istrations is difficult. Firstly, populations are different. For
example, the health care structure in the UK is totally dif-
ferent from that in Belgium, as there is free access to spe-
cialist care in Belgium. In general, GPs are informed about
all diseases of their patients including those who went
directly to a specialist. However, for young children who
only have been seen by a paediatrician and not by a GP,
this may not always be the case. Therefore, we used the
Yearly Contact Group instead of the Practice Population
for most analyses.
Although the method for estimating the Practice Popula-
tion is robust as it takes several influencing factors for con-
sultation rate into account, the true Practice Population
remains undefined[26]. Even in those countries with a
fixed registration to a particular GP, the true Practice Pop-
ulation is constantly changing. In the Belgian context,
uncertainty on the true practice population is even more
important. Therefore, calculations using the Practice Pop-
ulation should be considered with caution.
Because of free access to specialist care, our results should
be interpreted as the incidence rates of infections in gen-
eral practice only. Any decline in incidence could reflect a
true decline or a shift in consultation practices. This 'com-
petition' between general practice and paediatricians
explains the lower incidence of meningitis in our data as
compared to other morbidity registrations, because par-
ents with very young children in Belgium tend to consult
the paediatrician. The influence of differences in health
care structure could be the scope of further research.
The period of registration is another influencing factor, as
incidences of acute infections seem to be decreasing dur-
ing the last decade[21,27].
Finally, diagnoses are defined differently. The Transition
project uses the ICPC, the Weekly Returns Service uses the
ICD coding system, the Continuous Morbidity Registra-
tion an adapted version of the E list and the Intego net-
work an extensive own list, but we recoded all diagnoses
according to the ICPC-2 for analysis. For example, the
Weekly Returns Service reported a higher incidence of
meningitis of 9.4 infections per 1000 children less than
one year old, which can be explained by the fact that this
database contains unconfirmed cases.
Conclusion
In contrast to the total incidence of the selected acute
infections, serious infections are rare in general practice,
around 1% per year. Children younger than 4 years old
have the highest risk for serious infections, and incidence
of pneumonia peaks in the winter months.
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